What drug class does Vyvanse (lisdexamfetamine) belong to?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 21, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question

Vyvanse Drug Classification

Vyvanse (lisdexamfetamine) is a Schedule II controlled substance classified as a CNS (central nervous system) stimulant. 1

Regulatory Classification

  • Vyvanse contains lisdexamfetamine, a prodrug of amphetamine, which is designated as a Schedule II controlled substance by the DEA. This reflects its high potential for abuse and dependence. 1
  • The FDA classifies it specifically as a CNS stimulant for once-daily oral administration. 1, 2
  • In Japan, lisdexamfetamine is designated as raw material for stimulants and requires strict distribution control. 2

Pharmacological Mechanism

  • Lisdexamfetamine is an inactive prodrug that is hydrolyzed to its active form d-amphetamine (dextroamphetamine) in the blood following oral administration. 2, 3
  • The prodrug consists of l-lysine covalently bonded to dextroamphetamine, which is cleaved through rate-limited enzymatic hydrolysis on red blood cells. 3, 4
  • Once converted to d-amphetamine, it functions as a non-catecholamine sympathomimetic amine that blocks reuptake of norepinephrine and dopamine into presynaptic neurons and increases release of these monoamines into the extraneuronal space. 1, 2

Clinical Context Within Stimulant Class

  • Guidelines classify lisdexamfetamine alongside methylphenidate as first-line stimulant pharmacotherapy for ADHD. 5, 6
  • It is grouped with amphetamines as one of the two main stimulant classes (methylphenidate and amphetamines) approved for ADHD treatment. 6
  • The prodrug design distinguishes it from immediate-release amphetamines, with studies showing reduced "Drug Liking Effects" compared to immediate-release d-amphetamine at equivalent doses, though it still carries Schedule II classification due to abuse potential. 1

Important Caveats

  • Despite being a prodrug with theoretically lower abuse potential, Vyvanse still has high potential for abuse and misuse that can lead to substance use disorder. 1
  • The stimulant classification means it carries all standard warnings for CNS stimulants, including risks of cardiovascular events, growth suppression in children, and potential for physical and psychological dependence. 1

References

3
Research

Lisdexamfetamine.

Paediatric drugs, 2007

4
Research

Focus on Lisdexamfetamine: A Review of its use in Child and Adolescent Psychiatry.

Journal of the Canadian Academy of Child and Adolescent Psychiatry = Journal de l'Academie canadienne de psychiatrie de l'enfant et de l'adolescent, 2010

Related Questions

How can I manage appetite suppression caused by Vyvanse (lisdexamfetamine)?
Is routine blood monitoring required for patients taking lisdexamfetamine (Elvanse)?
Does the menstrual cycle affect the efficacy of Vyvanse (lisdexamfetamine)?
Can a female of childbearing age with Attention Deficit Hyperactivity Disorder (ADHD) take Vyvanse (lisdexamfetamine) with Yasmin (drospirenone and ethinyl estradiol) and Lion's Mane (Hericium erinaceus) together?
Is it safe to take Vyvanse (lisdexamfetamine) with Advil (ibuprofen) concurrently?
When is naproxen appropriate for pain management, and what dosing and monitoring are recommended?
Why does the trachea deviate toward the side of a pleural effusion in my patient?
What are the recommended doses of glycerin suppositories for adults and children with constipation?
In hospitalized patients with constipation, is docusate sodium combined with senna preferable to polyethylene glycol 3350 (Miralax) as first‑line therapy?
In a patient with stage 4 chronic kidney disease (eGFR ≈13 mL/min/1.73 m²) and mild hyperkalaemia, should diphenhydramine (Benadryl) and acetaminophen (Tylenol) be withheld?
For a 52‑year‑old woman presenting with 24‑hour right‑upper‑quadrant pain, jaundice, pale stools and dark urine, what is the initial diagnostic work‑up, the three most likely differential diagnoses, the anatomy of the biliary tree, the name and management of the acute deterioration with rigors, hypotension and confusion, and the definitive surgical procedure with three key consent points?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.